Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Oversight of direct-to-consumer neurotechnologies.

Wexler A, Reiner PB.

Science. 2019 Jan 18;363(6424):234-235. doi: 10.1126/science.aav0223. No abstract available.

2.

Perceptions of Undue Influence Shed Light on the Folk Conception of Autonomy.

Niker F, Reiner PB, Felsen G.

Front Psychol. 2018 Aug 8;9:1400. doi: 10.3389/fpsyg.2018.01400. eCollection 2018.

3.

Skillful Use of Technologies of the Extended Mind Illuminate Practical Paths Toward an Ethics of Consciousness.

Nagel SK, Reiner PB.

Front Psychol. 2018 Jul 19;9:1251. doi: 10.3389/fpsyg.2018.01251. eCollection 2018. No abstract available.

4.

Public Attitudes Towards Moral Enhancement. Evidence that Means Matter Morally.

Specker J, Schermer MHN, Reiner PB.

Neuroethics. 2017;10(3):405-417. doi: 10.1007/s12152-017-9340-9. Epub 2017 Jul 27.

5.

Scientific and ethical features of English-language online tests for Alzheimer's disease.

Robillard JM, Illes J, Arcand M, Beattie BL, Hayden S, Lawrence P, McGrenere J, Reiner PB, Wittenberg D, Jacova C.

Alzheimers Dement (Amst). 2015 Jul 2;1(3):281-8. doi: 10.1016/j.dadm.2015.03.004. eCollection 2015 Sep.

6.

Pre-Authorization: A Novel Decision-Making Heuristic That May Promote Autonomy.

Niker F, Reiner PB, Felsen G.

Am J Bioeth. 2016 May;16(5):27-9. doi: 10.1080/15265161.2016.1159761. No abstract available.

PMID:
27111363
7.

Perspective: Time to expand the mind.

Fitz NS, Reiner PB.

Nature. 2016 Mar 3;531(7592):S9. doi: 10.1038/531S9a. No abstract available.

PMID:
26934526
8.

Understanding public (mis)understanding of tDCS for enhancement.

Cabrera LY, Reiner PB.

Front Integr Neurosci. 2015 Apr 27;9:30. doi: 10.3389/fnint.2015.00030. eCollection 2015.

9.

Buttressing regulation of cognitive enhancement devices with principles of harm reduction.

Fitz NS, Reiner PB.

J Law Biosci. 2014 Sep 26;1(3):322-327. eCollection 2014 Sep.

10.

Attitudes towards prescribing cognitive enhancers among primary care physicians in Germany.

Franke AG, Papenburg C, Schotten E, Reiner PB, Lieb K.

BMC Fam Pract. 2014 Jan 8;15:3. doi: 10.1186/1471-2296-15-3.

11.
12.

The challenge of crafting policy for do-it-yourself brain stimulation.

Fitz NS, Reiner PB.

J Med Ethics. 2015 May;41(5):410-2. doi: 10.1136/medethics-2013-101458. Epub 2013 Jun 3.

13.

Autonomy support to foster individuals' flourishing.

Nagel SK, Reiner PB.

Am J Bioeth. 2013;13(6):36-7. doi: 10.1080/15265161.2013.781708. No abstract available.

PMID:
23641849
14.

Navigating the enhancement landscape. Ethical issues in research on cognitive enhancers for healthy individuals.

Forlini C, Hall W, Maxwell B, Outram SM, Reiner PB, Repantis D, Schermer M, Racine E.

EMBO Rep. 2013 Feb;14(2):123-8. doi: 10.1038/embor.2012.225. Epub 2013 Jan 15. No abstract available.

15.

Balancing autonomy and decisional enhancement: an evidence-based approach.

Castelo N, Reiner PB, Felsen G.

Am J Bioeth. 2012;12(2):30-1. doi: 10.1080/15265161.2011.634951. No abstract available.

PMID:
22304517
16.

Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.

Banjo OC, Nadler R, Reiner PB.

PLoS One. 2010 Dec 14;5(12):e14322. doi: 10.1371/journal.pone.0014322.

17.

Distinguishing between restoration and enhancement in neuropharmacology.

Reiner PB.

Virtual Mentor. 2010 Nov 1;12(11):885-8. doi: 10.1001/virtualmentor.2010.12.11.msoc1-1011. No abstract available.

18.

Stigma and addiction: being and becoming.

Buchman D, Reiner PB.

Am J Bioeth. 2009 Sep;9(9):18-9. doi: 10.1080/15265160903090066. No abstract available.

19.

Unintended benefits arising from cell-based interventions for neurological conditions.

Reiner PB.

Am J Bioeth. 2009 May;9(5):51-2. doi: 10.1080/15265160902788769. No abstract available.

PMID:
19396689
20.

Association of ABCA2 expression with determinants of Alzheimer's disease.

Chen ZJ, Vulevic B, Ile KE, Soulika A, Davis W Jr, Reiner PB, Connop BP, Nathwani P, Trojanowski JQ, Tew KD.

FASEB J. 2004 Jul;18(10):1129-31. Epub 2004 May 20.

PMID:
15155565
22.

beta-Amyloid efflux mediated by p-glycoprotein.

Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB.

J Neurochem. 2001 Feb;76(4):1121-8.

24.

Localization of the cGMP-dependent protein kinases in relation to nitric oxide synthase in the brain.

El-Husseini AE, Williams J, Reiner PB, Pelech S, Vincent SR.

J Chem Neuroanat. 1999 Sep;17(1):45-55.

PMID:
10569239
25.
28.

Novel effects of FCCP [carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone] on amyloid precursor protein processing.

Connop BP, Thies RL, Beyreuther K, Ida N, Reiner PB.

J Neurochem. 1999 Apr;72(4):1457-65.

29.

Monitoring neuronal NO release in vivo in cerebellum, thalamus and hippocampus.

Vincent SR, Williams JA, Reiner PB, el-Husseini A el-D.

Prog Brain Res. 1998;118:27-35. Review.

PMID:
9932432
30.

Regulation of amyloid precursor protein cleavage.

Mills J, Reiner PB.

J Neurochem. 1999 Feb;72(2):443-60. Review.

31.

Nitric oxide regulates cyclic GMP-dependent protein kinase phosphorylation in rat brain.

El-Husseini AE, Bladen C, Williams JA, Reiner PB, Vincent SR.

J Neurochem. 1998 Aug;71(2):676-83.

32.

Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway.

Mills J, Laurent Charest D, Lam F, Beyreuther K, Ida N, Pelech SL, Reiner PB.

J Neurosci. 1997 Dec 15;17(24):9415-22.

33.
35.

Histamine depolarizes cholinergic septal neurons.

Gorelova N, Reiner PB.

J Neurophysiol. 1996 Feb;75(2):707-14.

PMID:
8714646
36.
37.

State-dependent release of acetylcholine in rat thalamus measured by in vivo microdialysis.

Williams JA, Comisarow J, Day J, Fibiger HC, Reiner PB.

J Neurosci. 1994 Sep;14(9):5236-42.

38.

Isoflurane inhibits calcium currents in neocortical neurons.

Puil E, Hutcheon B, Reiner PB.

Neurosci Lett. 1994 Jul 18;176(1):63-6.

PMID:
7970239
40.

Reduced ionic conductance in turtle brain.

Doll CJ, Hochachka PW, Reiner PB.

Am J Physiol. 1993 Oct;265(4 Pt 2):R929-33.

PMID:
8238467
41.
42.
43.

Ca2+ channels: diversity of form and function.

Snutch TP, Reiner PB.

Curr Opin Neurobiol. 1992 Jun;2(3):247-53. Review.

PMID:
1322749
44.

Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitro.

Luebke JI, Greene RW, Semba K, Kamondi A, McCarley RW, Reiner PB.

Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):743-7.

45.
46.

Channel arrest: implications from membrane resistance in turtle neurons.

Doll CJ, Hochachka PW, Reiner PB.

Am J Physiol. 1991 Nov;261(5 Pt 2):R1321-4.

PMID:
1719828
47.

Effects of anoxia and metabolic arrest on turtle and rat cortical neurons.

Doll CJ, Hochachka PW, Reiner PB.

Am J Physiol. 1991 Apr;260(4 Pt 2):R747-55.

PMID:
1849377
48.

A pharmacological model of ischemia in the hippocampal slice.

Reiner PB, Laycock AG, Doll CJ.

Neurosci Lett. 1990 Nov 13;119(2):175-8.

PMID:
2280893
49.

Inhibition of rat brain histamine-N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA).

Cumming P, Reiner PB, Vincent SR.

Biochem Pharmacol. 1990 Sep 15;40(6):1345-50.

PMID:
2403387
50.

Supplemental Content

Loading ...
Support Center